BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30885344)

  • 1. Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung.
    Muley T; He Y; Rolny V; Wehnl B; Escherich A; Warth A; Stolp C; Schneider MA; Meister M; Herth FJ; Dayyani F
    Lung Cancer; 2019 Apr; 130():194-200. PubMed ID: 30885344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
    Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
    Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
    Wang Y; Wang Z; Ding Y; Sun F; Ding X
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2405-2407. PubMed ID: 31450913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC).
    Muley T; Rolny V; He Y; Wehnl B; Escherich A; Warth A; Stolp C; Schneider MA; Dienemann H; Meister M; Herth FJ; Dayyani F
    Lung Cancer; 2018 Jun; 120():46-53. PubMed ID: 29748014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker?
    Li M; Zhang Y; Jiang L; Li Y; Li G; Zhou J; Yang C; Li X; Qu W; Chen Y; Chen Q; Wang S; Xing J; Huang H
    Neoplasma; 2022 May; 69(3):729-740. PubMed ID: 35471981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring cytokeratin fragment 19 (CYFRA 21-1) serum levels for early prediction of recurrence of adenocarcinoma and squamous cell carcinoma in the lung after surgical resection.
    Yeh JJ; Liu FY; Hsu WH; Wang JJ; Ho ST; Kao A
    Lung; 2002; 180(5):273-9. PubMed ID: 12489021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Epididymis Protein 4 (HE4) in Patients with Small-Cell Lung Cancer.
    Wojcik E; Tarapacz J; Rychlik U; Stasik Z; Sas-Korczynska B; Skotnicki P; Kulpa JK
    Clin Lab; 2016 Sep; 62(9):1625-1632. PubMed ID: 28164590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung.
    Park SY; Lee JG; Kim J; Park Y; Lee SK; Bae MK; Lee CY; Kim DJ; Chung KY
    Lung Cancer; 2013 Feb; 79(2):156-60. PubMed ID: 23206831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
    Zhang T; Chu L; Tan W; Ye C; Dong H
    Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.
    Wu L; Chen X; Peng T; Tang E; Bai W; Chen L
    Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin fragment 19 (CYFRA 21-1) and carcinoembryonic antigen for early prediction of recurrence of lung adenocarcinoma.
    Kao CH; Hsieh JF; Ho YJ; Ding HJ
    Lung; 1999; 177(5):333-7. PubMed ID: 10467024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular metastasis in patients with metastatic lung cancer.
    Lin Q; Chen XY; Liu WF; Zhu PW; Shi WQ; Li B; Yuan Q; Min YL; Liu JM; Shao Y
    Cancer Med; 2020 Feb; 9(4):1279-1286. PubMed ID: 31218849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC).
    Stieber P; Zimmermann A; Reinmiedl J; Müller C; Hoffmann H; Dienemann H
    Anticancer Res; 1999; 19(4A):2665-8. PubMed ID: 10470216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HE4 in the Diagnosis and Follow Up of Non-Small Cell Lung Cancers.
    Huang W; Wu S; Lin Z; Chen P; Wu G
    Clin Lab; 2017 Mar; 63(3):461-467. PubMed ID: 28271686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?
    Nisman B; Lafair J; Heching N; Lyass O; Baras M; Peretz T; Barak V
    Cancer; 1998 May; 82(10):1850-9. PubMed ID: 9587116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer.
    Hanagiri T; Sugaya M; Takenaka M; Oka S; Baba T; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Takenoyama M; Yasumoto K; Tanaka F
    Lung Cancer; 2011 Oct; 74(1):112-7. PubMed ID: 21397974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin-19 fragment in the diagnosis of bladder carcinoma.
    Guo XG; Long JJ
    Tumour Biol; 2016 Oct; 37(10):14329-14330. PubMed ID: 27448817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
    Gauthé M; Richard-Molard M; Rigault E; Buecher B; Mariani P; Bellet D; Cacheux W; Lièvre A
    BMC Cancer; 2018 Apr; 18(1):417. PubMed ID: 29653564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.